Institutional Ownership
Shareholders
| Shareholder | Holders | Value ($MM) | % O/S | Shares |
|---|---|---|---|---|
| Institution | 267 | 493.36 | 54.29 | 76,489,504 |
| Mutual Fund | 229 | 256.04 | 23.39 | 28,678,437 |
| Insider | 17 | 4.20 | 0.33 | 461,434 |
Rotation
| Shareholder | Holders | Value Chg ($MM) | % O/S | Share Change |
|---|---|---|---|---|
| Buyers | 142 | 286.03 | 26.88 | 37,863,683 |
| Sellers | 126 | -122.00 | 13.21 | -18,616,994 |
| Net | 164.04 | 13.66 | 19,246,689 |
Concentration
| Value ($MM) | % O/S | Shares | |
|---|---|---|---|
| Total Inst. | 696.77 | 71.95 | 101,371,095 |
| Top 10 Inst. | 458.48 | 46.24 | 65,151,047 |
| Top 20 Inst. | 545.60 | 55.95 | 78,826,927 |
| Top 50 Inst. | 635.37 | 65.68 | 92,528,650 |
Style
| Holders | Value ($MM) | % Inst Shares | Shares | |
|---|---|---|---|---|
| Growth | 62 | 90.40 | 9.95 | 14,013,912 |
| Aggressive Growth | 5 | 3.45 | 0.38 | 541,056 |
| Core Growth | 46 | 57.79 | 6.31 | 8,893,645 |
| Growth | 11 | 29.17 | 3.25 | 4,579,211 |
| Income | 4 | 2.73 | 0.30 | 426,220 |
| Income Value | 2 | 2.59 | 0.29 | 406,233 |
| Yield | 2 | 0.14 | 0.01 | 19,987 |
| Index | 28 | 172.28 | 19.10 | 26,909,512 |
| Other | 84 | 190.57 | 20.98 | 29,557,650 |
| Broker Dealer | 17 | 18.67 | 2.08 | 2,926,572 |
| GARP | 36 | 72.89 | 7.88 | 11,095,630 |
| Hedge Fund | 29 | 98.80 | 11.00 | 15,502,790 |
| Specialty | 2 | 0.21 | 0.02 | 32,658 |
| Value | 38 | 21.28 | 2.21 | 3,109,404 |
| Core Value | 28 | 16.21 | 1.64 | 2,315,084 |
| Deep Value | 10 | 5.08 | 0.56 | 794,320 |
Location: Global Region
| Holders | % O/S | Shares | Share Value | |
|---|---|---|---|---|
| North America | 218 | 62.25 | 87,698,366 | 605,014,122 |
| Europe | 50 | 9.27 | 13,058,651 | 86,499,880 |
| Asia / Pacific | 15 | 0.43 | 605,891 | 4,991,205 |
| Africa | 1 | 0.01 | 8,187 | 74,092 |
Top Holders
| Holder | Shares Held | % O/S | Share Change | Filing Date |
|---|---|---|---|---|
| Biogen Inc | 24,420,157 | 17.33 | 24,420,157 | 4/8/20 |
| The Vanguard Group, Inc. | 8,554,638 | 6.07 | 66,134 | 3/31/20 |
| BlackRock Institutional Trust Company, N.A. | 8,284,387 | 5.88 | -245,509 | 3/31/20 |
| Wasatch Global Investors Inc | 5,938,434 | 4.22 | -1,548,583 | 3/31/20 |
| State Street Global Advisors (US) | 4,847,768 | 3.44 | 33,142 | 3/31/20 |
| Bellevue Asset Management AG | 3,850,000 | 2.73 | -- | 3/31/20 |
| Credit Suisse Asset Management | 2,717,669 | 1.93 | 309,087 | 3/31/20 |
| EcoR1 Capital, LLC | 2,308,079 | 1.64 | 2,308,079 | 3/31/20 |
| Dimensional Fund Advisors, L.P. | 2,196,935 | 1.56 | 12,353 | 3/31/20 |
| Tang Capital Management, LLC | 2,032,980 | 1.44 | 2,032,980 | 3/31/20 |
Top Holders: Mutual Funds
| Fund | Shares Held | % O/S | Share Change | Filing Date |
|---|---|---|---|---|
| SPDR S&P Biotech ETF | 3,852,901 | 2.73 | 1,216,622 | 6/30/20 |
| BB Biotech Fd | 3,850,000 | 2.73 | -- | 3/31/20 |
| Vanguard Total Stock Market Index Fund | 3,291,675 | 2.34 | -4,691 | 5/31/20 |
| iShares Russell 2000 ETF | 2,424,760 | 1.72 | 54,748 | 6/30/20 |
| Credit Suisse (Lux) Digital Health Equity Fund | 2,250,000 | 1.60 | -- | 1/31/19 |
| Vanguard Extended Market Index Fund | 1,706,503 | 1.21 | 21,058 | 5/31/20 |
| Wasatch Ultra Growth Fund | 1,617,910 | 1.15 | 552,520 | 3/31/20 |
| Vanguard Small-Cap Index Fund | 1,500,703 | 1.07 | -9,261 | 5/31/20 |
| iShares NASDAQ Biotechnology ETF | 1,431,547 | 1.02 | 66,355 | 6/30/20 |
| Wasatch Small Cap Growth Fund | 1,381,294 | 0.98 | -120,236 | 3/31/20 |
* Insider values reflect direct beneficial ownership.
Copyright Refinitiv